Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.

Blood - 11 Jan 2018

Mottok Anja, Jurinovic Vindi, Farinha Pedro, Rosenwald Andreas, Leich Ellen, Ott German, Horn Heike, Klapper Wolfram, Boesl Michael, Hiddemann Wolfgang, Steidl Christian, Connors Joseph M, Sehn Laurie H, Gascoyne Randy D, Hoster Eva, Weigert Oliver, Kridel Robert

Abstract excerpt

Follicular lymphoma (FL) is a clinically and molecularly highly heterogeneous disease, yet prognostication relies predominantly on clinical tools. We recently demonstrated that integration of mutation status of 7 genes, including EZH2 and MEF2B, improves risk stratification. We mined gene expression data to uncover genes that are differentially expressed in EZH2- and MEF2B-mutated cases. We focused on FOXP1 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to Enhancer of Zeste Homolog 2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, Follicular

Share to MEF2 Transcription Factors

Share to Prednisolone

Share to Prednisone

Share to Rituximab

Share to Vincristine

Source

Open in PubMed Open full text

Identifiers

PMID: 29122756
DOI: 10.1182/blood-2017-08-799080
PMCID: PMC5757687

Genes

FOXP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy.PMID 29122756Read ↗

The significance of FOXP1 in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.Semantic proximity Read ↗

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.Semantic proximity Read ↗

Decreased Expression of T-Cell-Associated Immune Markers Predicts Poor Prognosis in Patients with Advanced Follicular Lymphoma Received Rituximab Plus BendamustineSemantic proximity Read ↗

FOXP Transcription Factors in Thyroid Cancer: From Molecular Expression to Clinical SignificanceSemantic proximity Read ↗

FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cellsSemantic proximity Read ↗

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomasSemantic proximity Read ↗

Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.Semantic proximity Read ↗

Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1Semantic proximity Read ↗

FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.Semantic proximity Read ↗

Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.